Labcorp Holdings Inc. Files 8-K on Financials

TL;DR

Labcorp dropped its 8-K today, check the financials.

AI Summary

Labcorp Holdings Inc. filed an 8-K on October 24, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits. The company's principal executive offices are located at 358 South Main Street, Burlington, North Carolina.

Why It Matters

This 8-K filing provides an update on Labcorp's financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any unusual risks or events.

Key Players & Entities

• LABCORP HOLDINGS INC. (company) — Registrant
• October 24, 2024 (date) — Filing Date
• 358 South Main Street, Burlington, North Carolina 27215 (location) — Principal Executive Offices
• 336 - 229-1127 (phone_number) — Registrant's telephone number

FAQ

From the Filing

0000920148-24-000115.txt : 20241024 0000920148-24-000115.hdr.sgml : 20241024 20241024065810 ACCESSION NUMBER: 0000920148-24-000115 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20241024 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241024 DATE AS OF CHANGE: 20241024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 241390669 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20241024.htm 8-K lh-20241024 October 24, 2024 0000920148 false 0000920148 2024-10-24 2024-10-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 24, 2024 (Date of earliest event reported) LABCORP HOLDINGS INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1-11353 99-2588107 (State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 358 South Main Street   Burlington, North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act. Title of Each Class            Trading Symbol            Name of exchange on which registered Common Stock , $0.10 par value          LH                  New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).                                                      Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02 Results of Operations and Financial Condition Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated October 24, 2024 issue